chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got her vaccine, she was fine the first day, walking around, going to the mall, driving and no issues.  She went to bed and about 8:55 she woke up and was freezing.  She threw on an extra blanket on the bed and immediately she felt as if somebody had kicked her in the back with a boot all night long, and laid in bed and moan and drank water as she was thirsty.  She laid in bed the rest of the day.  She had pain in the injection site and swelling, and then she had joint pains.  It felt like all of her  joints had pain, slight headache.  She took some Ibuprofen for her symptoms.  Her husband came home and was able to assist her in eating and taking care of her.   The following day she was still tired and fatigued for about a week, but she was able to function and do her normal routine of things.
I believe that I now have a Shoulder Injury Related to Vaccine Administration from receiving the COVID-19 vaccine too high in my arm.  As it was being administered, I noticed that it took longer than usual for the nurse to get the contents of the vaccine into my arm, but I didn't think anything of it at the time.  I have never had a reaction to any vaccine and only the most mild tenderness if I would directly touch the injection site from a previous vaccine.  By mid-afternoon on 01/12/2021, I noticed that my arm was feeling sore.  I looked up the dosage of the Moderna Vaccine since it seemed like it took so long and I thought it might have just been a higher dose than something like the annual flu shot.  By the time I went to bed around 10pm, I could hardly move my shoulder/arm at all.  It was very difficult to get comfortable in bed that night, and I slept terribly because of the pain.  The next day, it was continued intense pain so I took Ibuprofen every few hours throughout the day, but it didn't seem to help.  After another restless night of sleep where my shoulder was throbbing even if I wasn't moving, I decided to contact my PCP.  They completed a virtual visit at 10:00am on 01/14/2021 and prescribed Prednisone for 5 days.  I picked it up on the same date and took the first dose around 11:45am, and as of 5:00pm on 01/14/2021 when I am writing this, I continue to have significant shoulder pain and limited range of motion.
This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 66-year-old female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced injection site erythema, injection site pain and feeling hot. On an unknown date, the outcome of the injection site erythema, injection site pain and feeling hot were recovered/resolved. It was unknown if the reporter considered the injection site erythema, injection site pain and feeling hot to be related to SHINGRIX. Additional details were received as follows: The age at vaccination was not reported. The reporter mentioned that, she knows a person at her gym who received a dose of SHINGRIX and had injection site reactions that were lasted for 1 to 2 days. The patient presented with redness and pain at the site and felt feverish for 1 to 2 days. The reporter did not know the patient's full name and provided the patient's age. The reporter did not consented to follow up.
On the 18th I felt fine in the morning, mid afternoon I had chills and headache then 102 fever. I had just returned the day before from an out of state trip. I went to urgent care and had a COVI-19 and flu test. Then the next morning 10/19 my temp was 99.9, highest that day without using Tylenol was 101.4 till later in the day the headache got worse, my legs were achy, sore throat and dry cough. Temp in evening was 101. On 20th my temp was normal range, I started with shortness of breath and coughing, I got minimal relief from my inhaler and my chest became very tight, temp 103.2; chills and weak legs. I switched to my nebulizer and took Tylenol. My Doctor gave me Amoxicillin.  I couldn't breath that night and was started on Azithromycin. I was diagnosis with bronchitis. My temp has come down but i am still with low grade temp. I finish the amoxicillin tomorrow.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 18-JUL-2013, the patient was vaccinated with PROQUAD (Merck) (dose strength and route was not reported) (lot # J000141 and expiry date: 04-JUL-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting PROQUAD (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for PROQUAD (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Papular urticaria on chest, arms & back - developed same day as FLUMIST given - seen in office 9/6/12 - ZYRTEC advised. Seen in hospital ER 9/6/12 - BENADRYL & DECADRON given.
Woke up Sunday morning and couldn't use left leg. Went to the ER, had imaging done on the left leg and was diagnosed with DVT with multiple small clots. Prescribed Eliquis for 6 months. Was called by CDC via using the V-Safe daily check in and asked to complete this form.
Immediate soreness at injection site, followed 2 days later by shoulder and arm pain and reduced range of motion. Burning sensation followed. 09/15/2014 went to primary physician, had an x-ray, then was sent to an orthopedic, went for physical therapy, specialist for few weeks then went for an MRI, after a few more weeks had a cortisone shot. Nothing seemed to help. Am still going to physical therapy. Still no improvement.
This spontaneous report was received from Licensed Practical Nurse (LPN), referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapy, drug and allergy history were not provided. On 03-JAN-2018, the patient was vaccinated with the second dose of PROQUAD (recombinant human albumin (rHA )) by intramuscular route (strength and dose were not provided), lot number N021728, expiration date 06-FEB-2019, for prophylaxis. Concomitant therapies included sterile diluent (lot number M034582, expiration date 27-APR-2019).    No adverse effects were reported.
trouble breathing; this time had more pain in arm/hard to move her arm; had trouble moving the arm up and down; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (this time had more pain in arm/hard to move her arm), INJECTED LIMB MOBILITY DECREASED (had trouble moving the arm up and down) and DYSPNOEA (trouble breathing) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019021A and 001A21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE, METOPROLOL, VALPROATE SEMISODIUM (DIVALPROEX), CALCITRIOL, CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]), VITAMIN D3, BIOTIN and CALCIUM CITRATE for an unknown indication.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Mar-2021, the patient experienced PAIN IN EXTREMITY (this time had more pain in arm/hard to move her arm) and INJECTED LIMB MOBILITY DECREASED (had trouble moving the arm up and down). On an unknown date, the patient experienced DYSPNOEA (trouble breathing). At the time of the report, PAIN IN EXTREMITY (this time had more pain in arm/hard to move her arm), INJECTED LIMB MOBILITY DECREASED (had trouble moving the arm up and down) and DYSPNOEA (trouble breathing) outcome was unknown.            Treatment medicines were not provided. The action taken with mRNA-1273 with the event was considered as not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-063972 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up information received contains significant information.Event outcome updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-063972:case for first dose
Noticed mild itching around site earlier this evening, then later tonight there is now an oblong raised and reddish area and 4" x 2". There are little red raised spots within this area. Itching has become a bit more intense and i applied some hydrocortisone cream.  It does still itch. This occurred on Day 9 if counting 3/26/2021 the day of injection as Day 1.
vaccine which has been punctured for about 19 hours has been administered to a patient/ First dose was administered on 30June2021 of an expired vial. Vial was first punctured at 5:30 PM on 29June2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine which has been punctured for about 19 hours has been administered to a patient/ First dose was administered on 30June2021 of an expired vial. Vial was first punctured at 5:30 PM on 29June2021) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine which has been punctured for about 19 hours has been administered to a patient/ First dose was administered on 30June2021 of an expired vial. Vial was first punctured at 5:30 PM on 29June2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine which has been punctured for about 19 hours has been administered to a patient/ First dose was administered on 30June2021 of an expired vial. Vial was first punctured at 5:30 PM on 29June2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by reporter. Treatment information was not provided.   This case was linked to MOD-2021-117613, MOD-2021-117667 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Added patient initials, Vaccine start date and dose number added.
Worst itching ever, all over his body after booster; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Worst itching ever, all over his body after booster) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Jan-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRURITUS (Worst itching ever, all over his body after booster). The patient was treated with TRIAMCINOLONE for Itching all over, at an unspecified dose and frequency. At the time of the report, PRURITUS (Worst itching ever, all over his body after booster) had not resolved.            No concomitant medication were provided. Patient visited his internist and the doctor prescribed Triamcinolone cream. The medicine did not help and he still has a problem, itching all over the body.   This case was linked to MOD-2022-512258, MOD-2022-512309 (Patient Link).
Information has been received from a registered nurse referring to a patient of unknown age and gender. On an unknown date the patient was vaccinated with improperly stored dose of (Merck) VARIVAX (lot number K002931, expiration date 26-FEB-2016, dose and route were unknown). No adverse effects were reported. Additional information is not expected because the reporter did not want to be contacted.
pt recv vax 22OCT96 & 23OCT96 pt devel vomit & diarrhea w/o fever 48hr p/vax;pharmacist related there were other pt that exp v,d who did not recv vax; this is 1 of 25 cases reported by a pharmacist;
Feeling Unwell; This is a spontaneous report from a contactable consumer (patient's husband). An 83-year-old female patient received bnt162b2 (reported as COVID vaccine), via an unspecified route of administration on 14Jan2021 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient's husband stated, she just received a Covid shot yesterday and she was not feeling well on 15Jan2021. The outcome of the event was unknown.  Pfizer is a marketing authorization holder of [COVID vaccine] in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of [COVID vaccine] has submitted the same report to the regulatory authorities.  No follow-up attempts are possible. Information about batch/lot number cannot be obtained.
Patient had previously had 1 dose of Moderna vaccine on 3/16/2021 which was not disclosed at time of vaccination for what should have been a 2nd dose of Moderna, but ended up being her first dose of the Pfizer COVID vaccine.  No adverse reaction noted at time of vaccination or in the days following.
Dizzy; Had accelerated heart rate; Severe fuzzy / foggy headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), HEART RATE INCREASED (Had accelerated heart rate) and HEADACHE (Severe fuzzy / foggy headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Tachycardia (Experienced years ago and heart rate reached 199) and Anemia (Severe anemia).    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced DIZZINESS (Dizzy), HEART RATE INCREASED (Had accelerated heart rate) and HEADACHE (Severe fuzzy / foggy headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency; METOPROLOL for Adverse event, at a dose of 1 1/2-tab in morning and 1 tab in the evening and WARFARIN SODIUM (COUMADIN) for Adverse event, at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizzy), HEART RATE INCREASED (Had accelerated heart rate) and HEADACHE (Severe fuzzy / foggy headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, Heart rate: high (High) Increased heart rate.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were reported.   Patients past medical history included tachycardia but reported that she didn't remember the onset time. She was also hospitalized at the time of occurrence but reported it was due to anemia. Patient had no history of COVID 19 infection and myocarditis.  The patient was administered with Tylenol and reported that it helped to calm down her heart rate but didn't helped from being wacko. She thought of not taking the second dose but later got it from a county fairground like the first dose. The patient had accelerated heart rate at midnight post first dose of vaccination. She had undergone EKG but was not aware about the results later it was opted to optimize the metoprolol dosage to see if it improves her condition in 2D Echocardiogram.   This case was linked to MOD-2021-315412 (Patient Link).
24 hours of high fever 09/20/03 and 09/21/03. Led to febrile convulsion. Seen 9/23/03, fever gone; scarletina form rash with tonsillitis.
This spontaneous report has been received from a Registered Nurse referring to an unspecified number of patients of unknown age and gender. Concurrent conditions and pertinent medical history were not reported. Since 28-MAY-2015, the patients were vaccinated with improperly stored doses of VARIVAX (Merck) (lot #, strength, route of administration and dose were not provided). No adverse experiences were reported. Product quality complaint (PQC) was not involved. Additional information is not expected because the reporter did not consent for follow up.
1st shot could lift arm all day and very dizzy felt sick for 3 days only, 2nd shot I went home and took a IB 800 like the guy told me because I told him about my reactions with the first one, I had no problems until the 4th or 5th day after the shot now I have continuing Joint aches,. pains in legs wrists. neck. its like my fibromyligia has came back in full force. I feel like crap! Headaches and hurt all over in my joints back just like I used to 20 years ago, I is very crappy!!
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 10-AUG-2016, the patient was vaccinated with the improperly stored dose of M-M-R II (lot # L026553, albumin status rHA; dose, route, expiration date were not reported). This is one of several reports received from the same reporter. Additional information has been requested.
Acute ringing in ears at an extremely high pitched level; It is constant and wakes me from sleep; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6202) via an unspecified route of administration in the left arm on 26Feb2021 at 16:30 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included systemic lupus erythematosis (reported as systemic lupus). The patient had no known allergies.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included methylprednisolone (MANUFACTURER UNKNOWN) for unknown indication, from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Feb2021 at 14:45 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the vaccination. On 15Mar2021 at 06:00, the patient experienced acute ringing in ears at an extremely high-pitched level.  It was constant and woke patient from sleep. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 05Apr2021, the patient underwent Polymerase Chain Reaction (PCR) test for COVID- 19 via nasal swab and the result was negative. The clinical outcome of the events acute ringing in ears at an extremely high-pitched level; it was constant and woke patient from sleep were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
10/09/21 - * 9:10pm:Moderate pain in the thyroid. The pain last around 3 hours. (Over the counter Acetaminophen 250mg) 10/10/21 - *10 am: Moderate pain in the thyroid. *11:20 am: Moderate Headache ; Moderate ear pain  (left ear more than the right). Pain still in course
Information has been received from a physician concerning a 16 year old female who on 20-NOV-2008 was vaccinated with the first dose of GARDASIL.  There was no concomitant medication.  Within two weeks after receiving GARDASIL (lot #661764/0650X), the patient experienced nausea and vomiting.  The patient's mother stated that her daughter will not receive the other 2 doses of GARDASIL.  About two weeks after being vaccinated, the patient recovered.  Additional information has been requested.
Patient is a 64 y.o. female patient of local MD with history of covid, carotid occlusion, CKD, DMII, COPD, CVA who is presented to local Medical Center with abnormal labs, flank pain.    Acute on CKD IV Fluid overload  HTN Follows with Dr. as OP Baseline Cr ~ 4 to 5 range  Cr 5.8 on admit; trended to 5.94 / K 4 (01/18)  CXR (01/17) with mild fluid overload  VIR consulted for permacath, placed 1/19 Nephrology consulted-plan to start HD, add renal vitamins Vascular consulted?Vein-mapping duplex resulted; L basilic appears adequate for AVF conduit No BP cuffs/IVs/blood draws to LUE Carotid artery disease; mgmt per neuro VIR. s/p dx cerebral angiogram 1/2022. Ok for discharge from vascular standpoint once duplex completed, signing off; 2 week f/u appt to be scheduled to review said duplex and discuss plan for AVF/AVG.  PT OT recs 2-3 days c/w HHC  O/p HD chair set up Palliative consulted   Covid-19 Virus Infection Date of onset of symptoms: 1/23/23 Symptoms present on admission: Nasal congestion, fever Date of covid positive test: 1/24/23 Vaccination status: vaccinated Imaging: CXR with pulm vascular congestion or bronchitis Oxygen requirements on admission: 2L PRN Current oxygen requirements: RA Medical therapy: not indicated Consultants following: e-consult to ID for Paxolvid Anticipated special isolation end date: 2/2/23   DM type 2 noninsulin dependent, Uncontrolled  A1c 12 Home regimen with Lantus 44U at HS, Lispro 11 U prandial TID Decreased to 40 units nightly, 7 prandial and SSI on admission Has been well controlled on Lantus 20u nightly. Dc home with 24u Nightly and titrate o/p as needed Continue Lantus and sliding scale insulin at reduced dose Glucagon prescribed on discharge and educated    Acute respiratory failure, hypoxic - Resolved H/o COPD Secondary to fluid overload and acute on chronic heart failure preserved EF Required 2L, now weaned off Continuous pulse ox Reports using 2L PRN at home Acute on chronic HFpEF  HTN, benign, controlled TTE (04/2021) w/ EF 61%, moderate LVH, LAE, mild AS Clinically mildly volume overloaded Continue home Coreg, Imdur, Nifedipine, and Aldactone  Continue telemetry    Migraine Headache History of CVA Residual L hemiparesis  Bilateral carotid stenosis Chronic / stable residual left hemiparesis, slight facial asymmetry  CT Brain-No acute intracranial abnormality.  Appearance of the brain is unchanged. Neurology consulted-Start topiramate 25 mg at bedtime Potential side effects discussed Dosage can be titrated upward as needed Pt will need outpatient follow up in 4-6 weeks Continue home Lipitor No home ASA or Plavix  Added Migraine cocktail   Anemia in CKD  Baseline Hgb ~ 10 to 11 Hgb 11 on admit, trended to 9.8 (01/18), 9.6 1/20, 9.8  1/21 HDS without active bleeding, monitor  Follows with Dr. and has had multiple admissions for acute on chronic anemia with GI workup  Seen by GI (last 02/2022); multiple EGD / C scope / push enteroscopy without obvious bleeding  Consulted-received procrit, now on HD, can resume eryhtropoetin with hemodialysis Follow   Itching - Resolved Secondary to CKD stage 4 Added Nivea lotion 1/20 Added prn Benadryl- ok per Nephrology Follow
Patient immediately began to feel sick she said she felt like she was going to faint.  She sat down and began saying that she couldn't see yet her eyes were wide open.  I watched her turn grey and her pupils dilate.  She then said that she could not feel her legs.  She was very weak.  She started getting severe stomach pains.  After about 10 mins we managed to move her to an exam room where she could lie down. At this point her hands locked into claws.   They remained locked for about 15 mins.   The PA gave her a can of ginger ale.  After about 20 mins after she drank it her color returned to her face, she began to feel her legs and her hands unlocked.  Total time from start to finish was approx 1 hour.